1. Home
  2. WFF vs QNRX Comparison

WFF vs QNRX Comparison

Compare WFF & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WF Holding Limited Ordinary Shares

WFF

WF Holding Limited Ordinary Shares

HOLD

Current Price

$0.40

Market Cap

10.8M

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$9.41

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFF
QNRX
Founded
1984
2018
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
10.1M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
WFF
QNRX
Price
$0.40
$9.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
191.2K
33.1K
Earning Date
12-31-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,021,079.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.45
N/A
52 Week Low
$0.38
$5.01
52 Week High
$29.26
$41.80

Technical Indicators

Market Signals
Indicator
WFF
QNRX
Relative Strength Index (RSI) 40.18 34.01
Support Level $0.38 $9.59
Resistance Level $0.51 $11.88
Average True Range (ATR) 0.04 0.84
MACD -0.00 -0.28
Stochastic Oscillator 8.52 2.95

Price Performance

Historical Comparison
WFF
QNRX

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: